Anthion Partners II Buys ~700K Shares of KaloBios Pharma (KBIO), Adding to Madness
Tweet
Share
E-mail
Get Alerts KBIO Hot Sheet
Join SI Premium – FREE
In addition to the Martin Shkreli buys on KaloBios Pharma (NASDAQ: KBIO) disclosed after the close, Anthion Partners II disclosed it bought 713,726 shares on 11/16 at $1.26-$1.76. Shares are up 700% after-hours.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morpheus shorts Velo3D: 'parlayed a failed SPAC and a sham SpaceX relationship into a fortune'
- Trump Administration Asks OpenAI to Stagger Release of New Model Over Security Concerns - Information
- Doncasters (DPC) indicating open around $40, IPO priced at $33
Create E-mail Alert Related Categories
Insider Trades, Momentum Movers, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
